Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224533 · ClinicalTrials.gov registry record
Walnut Consumption and Diabetes Risk
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 34,121
- Enrollment target
NCT03224533 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 34,121 participants.
The verdict
NCT03224533 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 34,121 participants
- Enrollment target
Study Summary
Multiple NHANES surveys were combined and weighted to evaluate relationships between walnut consumption and type 2 diabetes mellitus using various independent measures of diabetes status and risk. After risks were ascertained, interactions with gender were analyzed.
Interventions
- DIAGNOSTIC_TEST Diabetes Outcome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,121 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2017-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03224533
The ClinicalTrials.gov registry entry for NCT03224533 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34,121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Outcome is the first listed.
NCT03224533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03224533 about?
NCT03224533 is a clinical study titled "Walnut Consumption and Diabetes Risk". Multiple NHANES surveys were combined and weighted to evaluate relationships between walnut consumption and type 2 diabetes mellitus using various independent measures of diabetes status and risk. After risks were ascertained, interactions with gender were analyzed.
What is the current status of trial NCT03224533?
This trial is currently completed. The enrollment target is 34,121 participants. The study started on 2015-06-01. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT03224533?
The interventions under investigation include: Diabetes Outcome (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03224533?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.